(BCUS) Exchange Listed Funds Trust - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • • Large Blend

BCUS: Common Stock, Preferred Stock, Convertible Securities

The Exchange Listed Funds Trust (NYSE ARCA: BCUS) is an actively managed exchange-traded fund (ETF) that focuses on equity securities, primarily investing in common stocks, preferred stocks, and securities convertible into common stock. The fund adheres to a large-cap equity strategy, concentrating on U.S.-listed companies with significant market capitalizations. Under normal market conditions, the ETF allocates at least 80% of its net assets (plus borrowings for investment purposes) to these securities, ensuring a strong emphasis on established, large-scale businesses. This approach aligns with the funds objective of capturing growth and income opportunities within the large-cap segment of the U.S. equity market.

As of the latest data, the fund has an average trading volume of 29,131 shares over the past 20 days, with a last price of $29.50. Its short-term and medium-term moving averages (SMA 20: $30.67, SMA 50: $30.73) suggest a recent dip below its average price levels, while the SMA 200 ($30.18) indicates a slightly lower long-term trend. The Average True Range (ATR) of 0.35 reflects relatively low volatility, suggesting stable price movements. With assets under management (AUM) of $100.99 million, the fund maintains a moderate size, balancing liquidity with focused exposure to large-cap equities.

3-Month Forecast: Based on the provided data, the funds price is expected to remain range-bound between $29.00 and $31.00 over the next three months. The SMA 20 and SMA 50 are currently above the last price, indicating potential short-term downward pressure. However, the SMA 200 provides a floor near $30.18, suggesting long-term support. The low ATR of 0.35 signals manageable volatility, with average daily price fluctuations of less than 1%. The funds AUM of $100.99 million indicates a stable investor base, which may contribute to consistent trading volumes and limited liquidity risks. Overall, the outlook is neutral, with a slight bias toward stabilization near the SMA 200 level.

Additional Sources for BCUS ETF

BCUS ETF Overview

Market Cap in USD 110m
Category Large Blend
TER 0.70%
IPO / Inception 2023-12-20

BCUS ETF Ratings

Growth 5y 43.6%
Fundamental -
Dividend 1.0%
Rel. Strength -5.46
Analysts -
Fair Price Momentum 26.54 USD
Fair Price DCF -

BCUS Dividends

Dividend Yield 12m 0.17%
Yield on Cost 5y 0.20%
Annual Growth 5y -100.00%
Payout Consistency 100.0%

BCUS Growth Ratios

Growth Correlation 3m -62.9%
Growth Correlation 12m 71.4%
Growth Correlation 5y 84.7%
CAGR 5y 13.15%
CAGR/Max DD 5y 1.08
Sharpe Ratio 12m -0.19
Alpha -2.52
Beta 0.000
Volatility 14.67%
Current Volume 2.8k
Average Volume 20d 4.7k
What is the price of BCUS stocks?
As of March 31, 2025, the stock is trading at USD 29.15 with a total of 2,800 shares traded.
Over the past week, the price has changed by -1.86%, over one month by -3.11%, over three months by -4.24% and over the past year by +1.88%.
Is Exchange Listed Funds Trust a good stock to buy?
Partly, yes. Based on ValueRay Analyses, Exchange Listed Funds Trust (NYSE ARCA:BCUS) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 43.62 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BCUS as of March 2025 is 26.54. This means that BCUS is currently overvalued and has a potential downside of -8.95%.
Is BCUS a buy, sell or hold?
Exchange Listed Funds Trust has no consensus analysts rating.
What are the forecast for BCUS stock price target?
According to ValueRays Forecast Model, BCUS Exchange Listed Funds Trust will be worth about 28.7 in March 2026. The stock is currently trading at 29.15. This means that the stock has a potential downside of -1.65%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 28.7 -1.6%